We are live on ! Find out more
MWNA

Marshall Wace North America Portfolio holdings

AUM $23.5B
1-Year Est. Return 46.46%
This Fund
S&P 500
This Quarter Est. Return
+21.94%
1 Year Est. Return
+46.46%
3 Year Est. Return
+109.4%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$22.2B
AUM Growth
+$6.6B
Cap. Flow
+$3.75B
Cap. Flow %
16.89%
Top 10 Hldgs %
18.16%
Holding
1,735
New
565
Increased
342
Reduced
340
Closed
467

Top Buys

Rank Stock Value
1
TMO icon
Thermo Fisher Scientific
TMO
+$239M
2
AAPL icon
Apple
AAPL
+$213M
3
ELV icon
Elevance Health
ELV
+$188M
4
BMY icon
Bristol-Myers Squibb
BMY
+$184M
5
GOOG icon
Alphabet (Google) Class C
GOOG
+$166M

Top Sells

Rank Stock Value
1
ADBE icon
Adobe
ADBE
+$183M
2
ABBV icon
AbbVie
ABBV
+$149M
3
HUM icon
Humana
HUM
+$120M
4
FIS icon
Fidelity National Information Services
FIS
+$119M
5
MELI icon
Mercado Libre
MELI
+$103M

Sector Composition

Rank Sector Weight
1 Healthcare 27.33%
2 Technology 17.93%
3 Consumer Discretionary 11.98%
4 Financials 8.85%
5 Communication Services 8.6%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CENX icon
1226
Century Aluminum
CENX
$5.14B
$201K ﹤0.01%
+18,264
New +$166K
SNA icon
1227
Snap-on
SNA
$21.3B
$201K ﹤0.01%
+1,177
New +$197K
XENT
1228
DELISTED
Intersect ENT, Inc
XENT
$201K ﹤0.01%
+8,756
New +$167K
MSP
1229
DELISTED
Datto Holding Corp.
MSP
$200K ﹤0.01%
+7,432
New +$211K
TGH
1230
DELISTED
Textainer Group Holdings limited
TGH
$197K ﹤0.01%
+10,252
New +$175K
CDMO
1231
DELISTED
Avid Bioservices, Inc. Common Stock
CDMO
$195K ﹤0.01%
+16,889
New +$154K
GPRE icon
1232
Green Plains
GPRE
$1.06B
$194K ﹤0.01%
14,695
+4,320
+42% +$65.7K
CZOO
1233
DELISTED
Cazoo Group Ltd
CZOO
$191K ﹤0.01%
+8
New +$189K
HMHC
1234
DELISTED
Houghton Mifflin Harcourt Company
HMHC
$189K ﹤0.01%
+56,659
New +$169K
DCOM
1235
DELISTED
Dime Community Bancshares
DCOM
$185K ﹤0.01%
+11,708
New +$164K
ATRO icon
1236
Astronics
ATRO
$3.72B
$183K ﹤0.01%
+16,616
New +$136K
OEC icon
1237
Orion
OEC
$389M
$180K ﹤0.01%
+10,473
New +$160K
MNRL
1238
DELISTED
Brigham Minerals, Inc. Class A Common Stock
MNRL
$179K ﹤0.01%
16,353
-36,544
-69% -$377K
ADT icon
1239
ADT
ADT
$5.49B
$178K ﹤0.01%
+22,769
New +$179K
VECO icon
1240
Veeco
VECO
$3.02B
$176K ﹤0.01%
10,134
-240,942
-96% -$3.68M
HOLI
1241
DELISTED
Hollsys Automation Technologies INTERNATIONAL, LTD. COMMON (British Virgin Island)
HOLI
$175K ﹤0.01%
11,892
-2,874
-19% -$36.1K
EIGR
1242
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
$172K ﹤0.01%
+466
New +$134K
MLTX icon
1243
MoonLake Immunotherapeutics
MLTX
$1.47B
$164K ﹤0.01%
+15,099
New +$160K
TLMD
1244
DELISTED
SOC Telemed, Inc. Class A Common Stock
TLMD
$163K ﹤0.01%
+20,767
New +$183K
OTLKW
1245
CALL
DELISTED
Outlook Therapeutics, Inc. Series A Warrant Expiring 02/18/2022
OTLKW
$163K ﹤0.01%
+125,400
New +$20.9K
ERII icon
1246
Energy Recovery
ERII
$408M
$151K ﹤0.01%
+11,039
New +$118K
PRTA icon
1247
Prothena Corp
PRTA
$468M
$145K ﹤0.01%
+12,104
New +$143K
ONCY
1248
Oncolytics Biotech
ONCY
$95.8M
$141K ﹤0.01%
+59,300
New +$142K
NPTN
1249
DELISTED
NEOPHOTONICS CORP
NPTN
$127K ﹤0.01%
+13,987
New +$108K
XONE
1250
DELISTED
The ExOne Company
XONE
$125K ﹤0.01%
+13,166
New +$150K
48 49
50
51 52

Similar funds

TGHSA
TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return
PAM
PFM Asset Management Harrisburg, Pennsylvania $5.36B AUM 21.04% 1-Year Est. Return
HB
Homrich & Berg Atlanta, Georgia $4.47B AUM 22.61% 1-Year Est. Return
MWA
Marshall Wace Asia Central, Hong Kong $4.23B AUM 69.9% 1-Year Est. Return
3SCA
36 South Capital Advisors London, United Kingdom $3.76B AUM
HFCIV
H&F Corporate Investors VII San Francisco, California $3.61B AUM 26.49% 1-Year Est. Return
DVC
Deer VIII & Co Larchmont, New York $3.56B AUM
NAM
NorthCoast Asset Management Greenwich, Connecticut $2.74B AUM 25.44% 1-Year Est. Return

Marshall Wace North America's Q4 2020 Portfolio in Review

As of Q4 2020, Marshall Wace North America held 1,735 positions worth $22.2B, up 42% from $15.6B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Marshall Wace North America deployed $3.75B of net new capital in Q4 2020, opening 565 new positions and adding to 342 existing holdings. Its largest new stake was ExxonMobil: 2,686,885 shares worth $111M.

By sector, the portfolio is most concentrated in Healthcare at 27% of assets, down from 28% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was Adobe, an estimated $183M trimmed.

  • Marshall Wace North America's largest Q4 2020 buy was ExxonMobil: 2,686,885 shares worth $111M.
  • Marshall Wace North America added most to Thermo Fisher Scientific in Q4 2020, an estimated $239M increase.
  • Marshall Wace North America's biggest Q4 2020 reduction was Adobe, cutting an estimated $183M.
  • Marshall Wace North America fully exited Baxter International in Q4 2020, selling an estimated $92.8M.
  • Marshall Wace North America's ten largest holdings make up 18% of its $22.2B portfolio in Q4 2020.
  • Marshall Wace North America opened 565 new positions and closed 467 in Q4 2020.
  • Marshall Wace North America's portfolio value rose 42% quarter-over-quarter to $22.2B.

Based on Marshall Wace North America's 13F filing for Q4 2020, filed 16 Feb 2021.